Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical data trend for Valencia Nutrition's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:542910 vs VRTX, REGN, RVMD: FCF Margin % Comparison
For the Biotechnology subindustry, Valencia Nutrition's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Valencia Nutrition FCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Valencia Nutrition's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Valencia Nutrition's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Valencia Nutrition (BOM:542910) has a FCF Margin % of -276.18% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Valencia Nutrition and its competitors. According to the industry distribution chart, Valencia Nutrition ranks #651 out of 953 companies in the Biotechnology industry, placing it in the top 68.3%.
Is Valencia Nutrition's FCF Margin % too high?
Valencia Nutrition's current FCF Margin % is -276.18%. Based on the distribution chart, Valencia Nutrition ranks #651 out of 953 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Valencia Nutrition has a GF Score™ of 51/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Valencia Nutrition's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Valencia Nutrition ranks #651 out of 953 companies for FCF Margin %. This places Valencia Nutrition in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Valencia Nutrition and its competitors. Valencia Nutrition's current FCF Margin % is -276.18%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Valencia Nutrition stock overvalued right now?
Based on GuruFocus' analysis, Valencia Nutrition (BOM:542910) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹65.92, compared to a current price of ₹49.80 — trading 24.5% below its estimated fair value. The current FCF Margin % is -276.18%. Valencia Nutrition's overall GF Score™ is 51/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Valencia Nutrition (BOM:542910), the current FCF Margin % is -276.18% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Valencia Nutrition (BOM:542910) Overvalued in 2026?
Based on GuruFocus' analysis, Valencia Nutrition stock appears to be undervalued.
The current stock price of ₹49.80 is trading 24.5% below its estimated GF Value™ of ₹65.92.
GuruFocus considers Valencia Nutrition to be Modestly Undervalued.
Key valuation signals for BOM:542910:
FCF Margin %: -276.18%
GF Value™: ₹65.92 vs. price of ₹49.80 (24.5% below fair value)
No single metric tells the full story. See the BOM:542910 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Valencia Nutrition Ltd is a biotechnology company engaged in researching, developing, manufacturing, selling, and distributing nutraceutical products such as multi-nutrient functional beverages to prevent and/or manage lifestyle-related diseases. The company's products include Bounce Superdrinks and VitaMe Enriched Beverages.
51GF Score
Get the complete analysis for BOM:542910
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:542910 has been successfully added to your 
